DEVELOPMENT OF RITONAVIR LOADED NANOPARTICLES: IN VITRO AND IN VIVO CHARACTERIZATION
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i3.23145Keywords:
Ritonavir, Nanoparticle, Nanoprecipitation, Lyophilization, In vitro dissolution study, In vivo bioavailability studyAbstract
 Objective: The purpose of the present investigation was to develop a nanosuspension to improve dissolution rate and oral bioavailability of ritonavir.
Methods: Extended-release ritonavir loaded nanoparticles were prepared using the polymeric system by nanoprecipitation technique. Further, the effect of Eudragit RL100 (polymeric matrix) and polyvinyl alcohol (surfactant) was investigated on particle size and distribution, drug content, entrapment efficiency, and in vitro drug release from nanosuspension where a strong influence of polymeric contents was observed. Drug-excipient compatibility and amorphous nature of drug in prepared nanoparticles were confirmed by Fourier transform infrared spectroscopy, differential scanning calorimetry, and powder X-ray diffraction studies, respectively.
Results: Hydrophobic portions of Eudragit RL100 could result in enhanced encapsulation efficiency. However, increase in polymer and surfactant contents lead to enlarged particle size proportionately as confirmed by transmission electron microscopy. Nanosuspension showed a significant rise in dissolution rate with complete in vitro drug release as well as higher bioavailability in rats compared to the pure drug.
Conclusion: The nanoprecipitation technique used in present research could be further explored for the development of different antiretroviral drug carrier therapeutics.
Downloads
References
Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-20.
Dahan A, Miller JM, Amidon GL. Prediction of solubility and permeability class membership: Provisional BCS classification of the world’s top oral drugs. AAPS J 2009;11:740-6.
Benet LZ, Amidon GL, Barends DM, Lennernäs H, Polli JE, Shah VP, et al. The use of BDDCS in classifying the permeability of marketed drugs. Pharm Res 2008;25:483-8.
Hadinoto K, Zhu K, Tan RB. Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery. Int J Pharm 2007;341:195-206.
Breitenbach J. Melt extrusion: From process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107-17.
Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs. I. Prescription design. J Control Release 2002;81:65-74.
Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: Past, present and future. Nat Rev Drug Discov 2004;3:1023-35.
Gullapalli RP. Soft gelatin capsules (softgels). J Pharm Sci 2010;99:4107-48.
Sethia S, Squillante E. Solid dispersions: Revival with greater possibilities and applications in oral drug delivery. Crit Rev Ther Drug Carrier Syst 2003;20:215-47.
Davis SS, Washington C, West P, Illum L, Liversidge G, Sternson L, et al. Lipid emulsions as drug delivery systems. Ann N Y Acad Sci 1987;507:75-88.
Sham JO, Zhang Y, Finlay WH, Roa WH, Löbenberg R. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int J Pharm 2004;269:457-67.
Mahalingam M, Krishnamoorthy K. Camptothecin loaded poly (methacyclic acid-co-methyl-methyacrylate) nanoparticles: Fabrication, characterization and cytotoxicity studies. Int J Pharm Pharm Sci 2015;7:135-40.
Mishra R, Mir SR, Amin S. Polymeric nanoparticles for improved bioavailability of cilnidipine. Int J Pharm Pharm Sci 2017;9:129-39.
Sinha S, Ali M, Baboota S, Ahuja A, Kumar A, Ali J. Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS Pharm Sci Technol 2010;11:518-27.
Parboosing R, Maguire GE, Govender P, Kruger HG. Nanotechnology and the treatment of HIV infection. Viruses 2012;4:488-520.
Devi K, Pai R. Antiretrovirals: Need for an effective drug delivery.
Indian J Pharm Sci 2006;68:1.
Fessi C, Devissaguet JP, Puisieux F, Thies C. Process for the Preparation of Dispersible Colloidal Systems of a Substance in the form of Nanoparticles. US Patent No. 5118528 A; 1990.
Pouton CW. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and self-microemulsifying†drug delivery systems. Eur J Pharm Sci 2000;11 Suppl 2:S93-8.
Bilati U, Allémann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 2005;24:67-75.
Vetrichelvan T, Sowkar BI. Formulation and in vitro characterization of sustained release ritonovir nanoparticles in alginates. J Pharm Res 2011;44:2152-5.
Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1-12.
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47-60.
Serajuddin AT. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058-66.
Merisko-Liversidge E, Liversidge GG. Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev 2011;63:427-40.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
